financetom
Business
financetom
/
Business
/
US Airlines Likely to Report Strong Q4, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Airlines Likely to Report Strong Q4, UBS Says
Jan 7, 2025 12:23 PM

03:07 PM EST, 01/07/2025 (MT Newswires) -- US airlines are likely to report a strong Q4 with earnings either exceeding or coming in at the upper end of their guidance, UBS said in an earnings preview emailed Tuesday.

Demand remained "resilient" in the final weeks of 2024, resulting in a bullish outlook, UBS said. Q4 revenue growth accelerated about 400 basis points year over year on average when compared to Q3, the firm added, citing Bloomberg data.

With Q4 results out of the way, investors will be on the lookout for forward outlooks on key metrics, particularly revenue per available seat mile, or RASM, according to the note.

"In an environment with continuing cost inflation for airlines, we believe accelerating RASM growth is important for airlines to expand margins in 2025," UBS wrote.

UBS said it estimates around 4% RASM on average for Q1, excluding Alaska Air Group ( ALK ) , above the consensus of 2.5% to 3%.

"Those that report RASM upside to consensus are likely to be rewarded this reporting season as it will provide greater confidence on the achievability of 2025 estimates," UBS said.

Price: 60.97, Change: +0.93, Percent Change: +1.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved